GAM
CVS icon

Groupama Asset Management’s CVS Health CVS Stock Holding History

Groupama Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Buy
19,714
+7,631
+63% +$681K 0.03% 153
2026
Q1 		$868K Sell
12,083
-2,253
-16% -$174K 0.01% 230
2025
Q4 		$1.14M Sell
14,336
-1,300
-8% -$102K 0.02% 225
2025
Q3 		$1.18M Sell
15,636
-2,889
-16% -$198K 0.02% 235
2025
Q2 		$1.27M Buy
18,525
+9,803
+112% +$643K 0.02% 248
2025
Q1 		$586K Sell
8,722
-50,975
-85% -$3.05M 0.01% 316
2024
Q4 		$2.62M Sell
59,697
-20,410
-25% -$1.15M 0.05% 161
2024
Q3 		$4.04M Buy
80,107
+31,457
+65% +$1.84M 0.11% 117
2024
Q2 		$2.87M Sell
48,650
-22,996
-32% -$1.44M 0.04% 169
2024
Q1 		$7.8M Sell
71,646
-34,618
-33% -$2.64M 0.14% 117
2023
Q4 		$8.39M Buy
+106,264
New +$7.56M 0.22% 88

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Groupama Asset Management's CVS Position: Q2 2026 in Review

Groupama Asset Management increased its CVS Health (CVS) stake by 63% in Q2 2026, buying an estimated $681K and bringing the position to 19,714 shares worth $2.04M. The position accounts for 0.03% of the portfolio, ranked #153.

Groupama Asset Management first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.39M in Q4 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Groupama Asset Management held 19,714 shares of CVS Health worth $2.04M as of Q2 2026.
  • Groupama Asset Management bought 7,631 CVS Health shares in Q2 2026, an estimated $681K.
  • CVS Health made up 0.03% of Groupama Asset Management's portfolio in Q2 2026, its #153 holding.
  • Groupama Asset Management first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • Groupama Asset Management's CVS Health position peaked at $8.39M in Q4 2023.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.